Thursday, June 15, 2017

LabConnect Finds $24.5M

Seattle-based LabConnect, a provider of laboratory and support services for the biopharmaceuticals and medical device industries, has raised $24.5M in a Series A funding. The funding came from ABS Capital Partners, Pablo Capital, and BroadOak Capital. John Stobo of ABS Capital, Mark Anderson of Pablo Capital, and Tim Johnson of BroadOak Capital have all joined the company's board with the funding. Eric Hayashi is President and CEO of LabConnect. LabConnect provides its services to biopharmaceutical, medical device, and contract research organizations (CROs). More information »